These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5271994)

  • 1. Results of treatment of pulmonary tuberculosis with cycloserine in association with other drugs.
    Bethlem N
    Scand J Respir Dis Suppl; 1970; 71():244-9. PubMed ID: 5271994
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of pulmonary tuberculosis with ethionamide, cycloserine and pyrazinamide in Hong Kong.
    Horsfall PA
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():91-100. PubMed ID: 4662516
    [No Abstract]   [Full Text] [Related]  

  • 3. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis].
    Wagner J
    Gruzlica; 1966 Mar; 34(3):249-54. PubMed ID: 5947778
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK; Singh SK
    Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462
    [No Abstract]   [Full Text] [Related]  

  • 5. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical tolerance to cycloserine.
    Stephanopoulos C; Zoumbouloglou H
    Scand J Respir Dis Suppl; 1970; 71():235-8. PubMed ID: 5271993
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with cycloserine.
    Dissmann E
    Scand J Respir Dis Suppl; 1970; 71():239-43. PubMed ID: 5317744
    [No Abstract]   [Full Text] [Related]  

  • 8. [Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs].
    Zierski M; Zachara A
    Gruzlica; 1968; 37(1):31-8. PubMed ID: 5720035
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ethionamide and cycloserine in the treatment of middle-aged and aged patients with pulmonary tuberculosis].
    Vasil'eva IR; Zhmudskaia EV; Trifonova VK; Chesmochakova IV
    Probl Tuberk; 1970; 48(9):21-4. PubMed ID: 5518269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of treatment of pulmonary tuberculosis in adults with second line drugs].
    Ropek M; Szymański A; Chetkowski A; Tarocińska B
    Gruzlica; 1968 Oct; 36(10):1043-6. PubMed ID: 5710086
    [No Abstract]   [Full Text] [Related]  

  • 11. Late results of treatment of chronic drug-resistant pulmonary tuberculosis.
    Somner AR; Brace AA
    Br Med J; 1966 Mar; 1(5490):775-8. PubMed ID: 5910108
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of intolerance to cycloserine.
    Baroni V; Foddai G; Lukinovich N; Pontiggia P
    Scand J Respir Dis Suppl; 1970; 71():217-9. PubMed ID: 4318440
    [No Abstract]   [Full Text] [Related]  

  • 13. Limitations of the clinical activity of cycloserine therapy. Appearance of resistance to cycloserine when used alone and in combination with other drugs.
    Molina C
    Scand J Respir Dis Suppl; 1970; 71():296-305. PubMed ID: 5272000
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of treatment of patients with pulmonary tuberculous with a combination of cycloserine and other tuberculostatics.
    Raboukhine A
    Scand J Respir Dis Suppl; 1970; 71():155-8. PubMed ID: 5271977
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis].
    Baĭl'dinova IM
    Ter Arkh; 1971 Jan; 43(1):101-4. PubMed ID: 5574526
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis].
    Kekkaku; 1968 Feb; 43(2):91-5. PubMed ID: 5678013
    [No Abstract]   [Full Text] [Related]  

  • 18. Position of cycloserine in the treatment of pulmonary tuberculosis.
    Meyer A; Nadjar G
    Scand J Respir Dis Suppl; 1970; 71():139-43. PubMed ID: 5271974
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of treatment with a combined 3-drug regimen of secondary drugs in chronic cavernous pulmonary tuberculosis. A study under auspices of the International Union against Tuberculosis].
    Zierski M; Zacara A; Woźniak S
    Gruzlica; 1968 Sep; 36(9):809-18. PubMed ID: 4882450
    [No Abstract]   [Full Text] [Related]  

  • 20. Late results in re-treatment of patients with pulmonary tuberculosis.
    Zierski M; Zachara A
    Tubercle; 1970 Jun; 51(2):172-7. PubMed ID: 5493744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.